Jeffery Cross Participates in Debate on Impact of FTC’s Pay-for-Delay Challenge

The U.S. Supreme Court hears arguments next week in a case challenging payments made by brand-name drug companies to generic firms to settle patent lawsuits. Jeffery Cross, a member of Freeborn’s Litigation Practice Group and Antitrust Team, joins the debate on the potential impact of the so-called “Pay-for-delay challenge,” in an online forum with Thomson Reuters.

To read the full article, click here.